What is EGCG and what makes green tea different?

Green tea (Camellia sinensis) is produced by steaming or pan-firing fresh tea leaves immediately after harvest, halting the enzymatic oxidation (often inaccurately called "fermentation") that converts catechins into theaflavins and thearubigins in black tea. This minimal processing preserves the four major catechins in their unoxidised forms: epigallocatechin-3-gallate (EGCG), epigallocatechin (EGC), epicatechin-3-gallate (ECG), and epicatechin (EC). Of these, EGCG is by far the most abundant, comprising 50 to 80% of total catechin content and the majority of green tea's documented biological activity.

EGCG has three hydroxyl-bearing rings and a galloyl group that collectively give it exceptional polyphenol reactivity. It binds to bacterial cell membrane proteins, intercalates into DNA, inhibits various enzyme systems, and modulates eukaryotic cell signalling pathways. This broad reactivity explains why EGCG has been studied against such diverse targets: cancer cells, viral pathogens, metabolic syndrome, and, most relevantly here, oral bacteria and gingival inflammatory pathways.

The concentration of EGCG in a cup of green tea varies considerably with tea variety, growing conditions, water temperature (higher temperatures extract more catechins), and steeping time. A standard 200 mL cup of Japanese sencha steeped at 70 to 80 degrees Celsius for 2 minutes delivers approximately 50 to 100 mg of catechins, of which 30 to 60 mg may be EGCG. Chinese green teas vary similarly. The bioavailability of EGCG from brewed tea in humans is modest; plasma EGCG peaks at approximately 0.1 to 0.5 micromoles per litre after a single cup, with elimination over 2 to 4 hours, necessitating multiple daily servings to maintain elevated tissue concentrations.

Green tea also contains L-theanine, an amino acid with anxiolytic properties, caffeine (in lower amounts than coffee), and a range of minor flavonoids. In the oral cavity, these compounds reach the gingival tissue both topically during tea consumption and systemically via the circulation after intestinal absorption. The topical route is pharmacologically significant for the sulcular and gingival epithelium, as catechin concentrations in the oral cavity during and shortly after tea drinking can be orders of magnitude higher than systemic plasma concentrations.

EGCG and periodontal pathogens: antimicrobial activity in vitro

In laboratory conditions, EGCG shows antimicrobial activity against a wide range of oral bacteria. Its mechanism of action combines direct membrane disruption (EGCG disrupts bacterial lipid bilayers, particularly in Gram-positive species), enzyme inhibition (many bacterial enzymes are competitively inhibited by EGCG's polyphenol structure), and interference with quorum sensing signalling that co-ordinates bacterial community behaviours in biofilms.

Against Streptococcus mutans, EGCG inhibits both glucosyltransferase (as does cranberry PAC, discussed in a sibling article) and fructosyltransferase, the enzyme that synthesises fructan polysaccharides also used in plaque matrix construction. Minimum inhibitory concentrations for S. mutans in vitro are typically in the range of 125 to 500 micrograms per millilitre, achievable in the oral cavity during active green tea consumption.

Against periodontal pathogens, the evidence from research published in Clinical Oral Investigations and the Journal of Periodontology shows EGCG minimum inhibitory concentrations of 31 to 250 micrograms per millilitre for Porphyromonas gingivalis, 62 to 500 micrograms per millilitre for Tannerella forsythia, and 250 to 1,000 micrograms per millilitre for Treponema denticola (the most resistant of the "red complex" pathogens). EGCG also inhibits gingipain cysteine proteases of P. gingivalis at sub-inhibitory concentrations, reducing virulence without necessarily reducing viable bacterial count, a potentially useful property if the goal is reducing tissue damage rather than eradicating bacteria.

Biofilm inhibition studies show that EGCG disrupts established P. gingivalis biofilms at concentrations above 250 micrograms per millilitre. At sub-MIC concentrations, EGCG reduces biofilm biomass and metabolic activity without complete eradication, a mode of action that may reduce selection pressure for resistance compared to bactericidal antiseptics used at supralethal concentrations.

Anti-inflammatory mechanisms: NF-kB, cytokines, and matrix metalloproteinases

Beyond its direct antimicrobial activity, EGCG has well-characterised anti-inflammatory properties in human cell systems that are directly relevant to the tissue destruction pathways operating in periodontitis. These effects are mediated through three key mechanistic pathways.

NF-kB suppression

Nuclear factor kappa-B (NF-kB) is the master transcription factor controlling the expression of most pro-inflammatory cytokines and adhesion molecules. In periodontitis, bacterial lipopolysaccharide and cytokines from neighbouring immune cells continuously activate NF-kB in gingival fibroblasts and epithelial cells, producing a sustained inflammatory environment. EGCG inhibits NF-kB activation by preventing IKK-beta phosphorylation of the inhibitory IkB subunit, blocking IkB degradation, and preventing NF-kB translocation to the cell nucleus. This single-target action upstream of multiple inflammatory mediators gives EGCG a broad anti-inflammatory effect without the off-target effects of NSAIDs or corticosteroids.

Cytokine reduction

Studies using human gingival fibroblast cell lines stimulated with P. gingivalis LPS have found that EGCG pretreatment significantly reduces secretion of interleukin-1 beta, interleukin-6, interleukin-8, and prostaglandin E2 compared to untreated controls. These are the key mediators driving osteoclast activation (bone loss), neutrophil recruitment (oxidative burst), and pain sensitisation in the periodontal pocket. Gingival crevicular fluid from periodontitis patients collected during the clinical trials cited below showed reduced IL-1 beta concentrations in the EGCG treatment groups, suggesting the in vitro mechanisms translate into measurable changes at the disease site in humans.

Matrix metalloproteinase inhibition

Matrix metalloproteinases (MMPs), particularly MMP-1, MMP-2, MMP-8, and MMP-13, are the collagenolytic enzymes responsible for the irreversible destruction of collagen fibres in the periodontal ligament and gingival connective tissue. EGCG inhibits multiple MMP isoforms through zinc chelation (the catalytic site of all MMPs contains a zinc ion), reducing the rate of connective tissue breakdown. A study in the Journal of Periodontal Research demonstrated that EGCG at concentrations of 50 to 100 micrograms per millilitre inhibited MMP-1 activity by approximately 70% in human gingival fibroblast cultures. This MMP-inhibitory activity is considered one of the most clinically significant mechanisms for tissue preservation in the context of active periodontitis.

Human clinical trial evidence: what the randomised studies show

A widely cited cross-sectional study published in the Journal of Periodontology in 2009 analysed data from 940 male participants in a Japanese health survey. Each additional daily cup of green tea was associated with a 0.023 mm decrease in mean periodontal pocket depth, a 0.025 mm reduction in mean clinical attachment loss, and a 0.63% reduction in bleeding on probing rate. While modest in absolute terms and unable to establish causality, this dose-dependent association in a large sample is consistent with a genuine biological relationship.

Among interventional trials, a 2012 randomised study published in Clinical Oral Investigations compared scaling and root planing alone to scaling plus an adjunctive 2% EGCG gel applied into periodontal pockets at baseline, 4 weeks, and 8 weeks in 30 patients with moderate chronic periodontitis. At 12 weeks, the EGCG group showed statistically significant improvements in probing pocket depth (mean reduction 1.03 mm vs 0.72 mm in control), clinical attachment level gain (0.88 mm vs 0.61 mm), and bleeding on probing reduction (42% vs 26%). Gingival crevicular fluid IL-1 beta was significantly lower in the EGCG group at 8 and 12 weeks, providing biochemical confirmation of the anti-inflammatory mechanism.

A separate trial investigated green tea catechin chips (biodegradable controlled-release devices placed subgingivally after scaling) in 44 patients with residual pockets of 5 to 8 mm. Published in the Journal of Periodontology, the study found that EGCG chip placement produced significantly greater pocket depth reduction and attachment gain than scaling alone at 6 months, comparable to results from locally delivered chlorhexidine chips but without the staining, dysgeusia, and microbiome disruption associated with chlorhexidine.

For gingivitis (the reversible precursor to periodontitis), a 2009 randomised trial comparing a 0.5% EGCG mouthwash to 0.12% chlorhexidine in 40 patients with plaque-induced gingivitis found equivalent reductions in plaque index and gingival index at 8 weeks, with the EGCG group reporting significantly less staining and better taste acceptability. The authors noted that chlorhexidine produced greater bacterial count reductions but that the clinical gingival outcomes were indistinguishable, suggesting that EGCG's anti-inflammatory pathway (rather than pure antibacterial killing) may be sufficient to control mild gingivitis.

Green tea catechins and the oral microbiome

Regular green tea consumption appears to produce measurable shifts in the composition of the oral microbiome, not just reductions in total bacterial count. Several cross-sectional and interventional studies have examined microbiome composition using 16S rRNA sequencing or traditional culture methods before and after green tea interventions.

A 2020 cross-sectional study published in the Journal of Dentistry compared subgingival plaque microbiome profiles from Japanese adults who drank 3 or more cups of green tea daily versus those who drank fewer than 1 cup per day. The high-consumption group showed significantly lower relative abundances of Porphyromonas gingivalis, Treponema denticola, and Fusobacterium nucleatum, the three species most consistently associated with progressive periodontitis, after adjustment for age, smoking, and oral hygiene frequency. Relative abundances of health-associated species including Streptococcus sanguinis and Rothia mucilaginosa were higher in the green tea group.

These microbiome differences could reflect EGCG's selective antimicrobial activity, the anti-adhesion properties of catechin-salivary protein complexes altering the pellicle composition, or systemic anti-inflammatory effects that shift the host tissue environment toward one less hospitable to anaerobic pathogens. Distinguishing between these mechanisms in observational data is not possible, but the consistency of the association across studies suggests a genuine biological relationship.

Importantly, unlike chlorhexidine, EGCG does not appear to broadly suppress the oral microbiome at typical dietary intake concentrations. Studies comparing plaque diversity scores between green tea drinkers and non-drinkers generally do not find significant differences in overall species richness or Shannon diversity index, suggesting that green tea preferentially affects periodontal pathogens over commensal species. This microbiome-selective profile is desirable, as it preserves the health-associated bacterial community while targeting pathogenic species.

EGCG in toothpastes and mouthwashes: what formulation research shows

The incorporation of EGCG into oral care products faces several formulation challenges. EGCG is chemically unstable, particularly at alkaline pH and elevated temperature. Most toothpastes are formulated at pH 6.0 to 8.0; at the alkaline end of this range, EGCG undergoes rapid auto-oxidation, losing much of its bioactivity within weeks to months of shelf storage. Early green tea toothpastes used raw tea extract without stabilisation and likely delivered little active EGCG by the time of use.

More recent formulations using microencapsulation of EGCG in liposomes or cyclodextrin inclusion complexes have shown substantially better stability in both shelf storage tests and in vitro antimicrobial potency assays after storage. A 2021 study in the BDJ Open compared a stabilised EGCG toothpaste (using cyclodextrin encapsulation) to a standard fluoride toothpaste in 60 adults with mild gingivitis over 8 weeks. The EGCG group showed significantly lower gingival index and bleeding scores at 8 weeks, with plaque index reductions comparable to the fluoride group. The study did not include a positive control chlorhexidine group, limiting conclusions about the relative magnitude of effect.

EGCG mouthwashes at concentrations of 0.1 to 0.5% have been tested in multiple small trials, generally showing results comparable or superior to placebo rinse and non-inferior to chlorhexidine for gingival clinical parameters, without chlorhexidine's staining, taste, and microbiome disruption side effects. The main advantage of mouthwash over toothpaste as an EGCG delivery vehicle is extended contact time with gingival tissue, not limited to the brushing stroke.

Green tea and salivary parameters: pH, flow, and fluoride

Green tea consumption produces several changes in salivary parameters that are relevant to oral health beyond its direct effects on bacteria and gingival tissue.

Salivary pH rises modestly after green tea consumption compared to water, an effect attributed to the alkalinising properties of catechin-salivary protein complexes and to green tea's fluoride content. Green tea is a naturally fluoride-rich beverage, containing 0.1 to 0.9 mg of fluoride per 100 mL depending on the fluoride content of the water used in growing and processing. Three cups of green tea per day can contribute 0.2 to 0.5 mg of fluoride to total daily intake, a meaningful fraction of the optimal 3 to 4 mg recommended for adults. This fluoride contribution, combined with the slightly elevated post-drinking salivary pH, provides a modest but consistent anti-erosion environment at the enamel surface.

Green tea catechins also bind to salivary amylase and mucin, modifying the composition of the salivary pellicle that forms on teeth after cleaning. Some research suggests that EGCG-modified pellicles are less adhesive for S. mutans compared to unmodified pellicles, providing a surface-level anti-adhesion benefit in addition to the direct anti-bacterial and anti-adhesin effects of catechins in solution.

The effect on salivary flow rate is controversial. Some older studies suggested caffeine in tea stimulates salivary gland activity; more controlled studies accounting for the hydration effect of the beverage volume itself find no significant catechin-specific effect on resting salivary flow rate. For dry mouth patients, the hydration from consuming tea provides some relief, but there is no evidence that green tea specifically stimulates salivary gland secretion beyond the mechanical and hydration stimulus of any liquid.

Incorporating green tea into an oral care routine

The evidence for green tea in oral health is sufficiently consistent to justify regular consumption as part of a broader oral health strategy. The following framework represents a practical approach.

Aim for 3 to 5 cups of brewed green tea per day, using water at 70 to 80 degrees Celsius rather than boiling (lower temperatures extract more EGCG relative to caffeine and produce a less bitter taste). Avoid adding sugar or honey, which directly undermines any microbiome benefit. Consume tea with or after meals rather than sipping continuously throughout the day to allow salivary pH to recover fully between acid and tannin exposures.

For those who prefer not to drink 3 to 5 cups of tea daily, EGCG supplements standardised to 200 to 400 mg EGCG per dose taken once or twice daily provide the systemic catechin exposure without the beverage volume. Research on bioavailability of supplement EGCG versus brewed tea EGCG shows broadly comparable plasma concentration-time profiles for equivalent EGCG doses, though the food matrix of brewed tea may provide modest absorption advantages.

Enamel health requires interventions that green tea alone cannot provide. Nano-hydroxyapatite or fluoride applied to the enamel surface is necessary for remineralisation because enamel, being nearly 97% hydroxyapatite with no living cells, can only recover mineral through surface ion exchange. Minvelle remineralising gum provides this through nano-hydroxyapatite and xylitol, working at the enamel surface level with every chewing session. Green tea working at the gum tissue level and a remineralising gum working at the enamel surface level are complementary strategies that address different parts of the oral health equation simultaneously.

Frequently asked questions